Precision Therapeutics Announces Completion of Merger with Helomics Holding Corporation

    NEXT STORY
    Oncology Ventures styrelse beslutar om att genomföra en företrädesemission
    PREV STORY
    NexImmune Management to Present at Upcoming Conferences
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Celyad announces initiation of the SHRINK trial

    SHRINK study to evaluate the synergetic effect of the concurrent administration of CYAD-01 (CAR-T ...

    author_avatar
    NASDAQ Market News

    Emergency Medical Supplies & Equipment Market to hit USD 50 Bn by 2026: Global Market Insights, Inc.

    author_avatar
    NASDAQ Market News

    XBiotech Announces First Patient in Clinical Study to Evaluate Bermekimab in Systemic Sclerosis

    author_avatar
    NASDAQ Market News